Equity Method Investment and Note Receivable - Summarized Financial Information (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Net sales					$ 1,660,000,000
Income (loss) from continuing operations	$ 603,000,000	$ 255,000,000	$ 1,432,000,000	$ 1,430,000,000
Net income (loss)	9,366,000,000	952,000,000	12,462,000,000	2,522,000,000
Net income (loss) attributable to shareholders	9,352,000,000	$ 921,000,000	12,475,000,000	$ 2,491,000,000
Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Schedule of Equity Method Investments [Line Items]
Net sales	435,000,000		435,000,000
Gross profit	108,000,000		108,000,000
Income (loss) from continuing operations	(150,000,000)		(150,000,000)
Net income (loss)	(150,000,000)		(150,000,000)
Net income (loss) attributable to shareholders	$ (153,000,000)		$ (153,000,000)